Biopharma Business

Tag "Samsung Bioepis"

Pro-Samsung U.K. court ruling hurts AbbVie’s defense against Humira biosims

Score one for Samsung Bioepis in its quest to bring a biosimilar version of AbbVie’s anti-inflammatory behemoth Humira to market in Europe. This week, a U.K. court upturned two of the

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here